Print Page | Close Page

 
 

Capsugel

Address: 412 Mt. Kemble Ave, Suite 200C, Morristown, NJ 07960
 
Country: USA
 
Parent: Lonza Group
 
Sectors: Contract Manufacturing
 
Telephone: +1 862-242-1700
 
Website: http://www.capsugel.com
 
- - -
 

About Us

Capsugel — now a Lonza company — designs, develops and manufactures a wide range of innovative dosage forms for the biopharmaceutical and consumer health & nutrition industries. Our unique combination of science, engineering, formulation and capsule expertise enables our customers to optimize the bioavailability, targeted delivery and overall performance of their biopharmaceutical and consumer health & nutrition products. We partner with more than 4,000 customers in over 100 countries to create novel, high-quality and customized solutions that align with our customers’ evolving needs and benefit patients and consumers.

 
- - -
 

Sectors

  • Contract Manufacturing
 
 
- - -
 

Categories

  • Finished Dosage
  • Drug Delivery Technology
  • Capsules-Vegetarian
  • Capsules-Liquid Filled
  • Capsule within a capsule
  • Capsules-Soft Gelatin
 
  • Corporate Headquarters
  • Capsules-Hard Gelatin
  • Capsule Filling
  • Capsules-General
  • Controlled Release
  • Micronisation
 
- - -
 

News

 
19th October 2016
 

Capsugel Expands Capabilities for Early-Phase Development through Commercial Manufacturing across Multiple Locations in Europe

 
Morristown, N.J., October 3, 2016 – Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, today announced that it is expanding the technology platforms and capabilities at its product development and manufacturing sites in Edinburgh, Scotland, and Ploërmel and Strasbourg, France.
 
-
 
 
19th October 2016
 

Capsugel Launches Vcaps® Enteric Capsules for Enteric Protection and Delayed Release

 
Extension of the company’s intrinsically enteric capsule portfolio can accelerate product development and reduce costs by eliminating the need for functional coating

Morristown, N.J., October 7, 2016 – Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, recently announced the launch of its Vcaps® Enteric capsules, a new functional capsule technology that achieves enteric protection and delayed release without the need for functional coating. The new capsules provide Capsugel’s customers with another solution for intrinsically enteric delivery, complementing the company’s enTRinsic™ Drug Delivery Technology launched in late 2015.
 
- - -
 
Printed: 12-May-2026 at 09:35:39 hrs
Source: The Partnership Tree | https://www.pharmaservicesdirectory.com